Add-on to Micamlo BP Trial

Summary

Add-on to Micamlo BP Trial is a clinical trial^[1].

Key Facts

• Add-on to Micamlo BP Trial is in the country of Japan^[2].
• Add-on to Micamlo BP Trial's instance of is recorded as clinical trial^[3].
• Add-on to Micamlo BP Trial's start time is recorded as +2013-11-30T00:00:00Z^[4].
• Add-on to Micamlo BP Trial's end time is recorded as +2014-06-30T00:00:00Z^[5].
• Add-on to Micamlo BP Trial's sponsor is recorded as Boehringer Ingelheim^[6].
• Add-on to Micamlo BP Trial's main subject is recorded as arterial hypertension^[7].
• Add-on to Micamlo BP Trial's number of participants is recorded as {'unit': '1', 'amount': '+309'}^[8].
• Add-on to Micamlo BP Trial's title is recorded as An Eight-week Randomised Double-blind Study to Compare the Efficacy and Safety of Telmisartan 80 mg and Amlodipine 5 mg and Hydrochlorothiazide 12.5 mg vs. Telmisartan 80 mg and Amlodipine 5 mg in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Telmisartan 80 mg and Amlodipine 5 mg^[9].
• Add-on to Micamlo BP Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+20'}^[10].
• Add-on to Micamlo BP Trial's ClinicalTrials.gov ID is recorded as NCT01975246^[11].
• Add-on to Micamlo BP Trial's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+100'}^[12].
• Add-on to Micamlo BP Trial's research intervention is recorded as telmisartan^[13].
• Add-on to Micamlo BP Trial's research intervention is recorded as amlodipine / atorvastatin^[14].
• Add-on to Micamlo BP Trial's research intervention is recorded as hydrochlorothiazide^[15].
• Add-on to Micamlo BP Trial's clinical trial phase is recorded as phase III clinical trial^[16].
• Add-on to Micamlo BP Trial's research subject recruitment status is recorded as completed^[17].
• Add-on to Micamlo BP Trial's study type is recorded as interventional study^[18].